Broadcom (AVGO): Among Oppenheimer’s Best Picks
In its latest research report, Oppenheimer ranked Broadcom (AVGO) as a favorite due to strong revenue growth and high margin performance. The company posted $5.5 billion in revenue for Q4 2023, reflecting a 20% increase.
Broadcom’s diversified product portfolio—including data‑center, telecommunications equipment, and IoT solutions—provides a hedge against macroeconomic volatility and strengthens its market share.
The firm also demonstrated robust cash‑flow and capital‑management metrics, generating $3.2 billion in free cash flow in 2023. While reducing debt by $1.5 billion, Broadcom enhanced shareholder value through dividend payments and a share‑repurchase program.
Oppenheimer projects 15% growth and a 30% gross‑margin target for 2024, positioning the company above industry averages.
This is not investment advice.
📊 AVGO — Piyasa Yorumu
▲ up · 70%AVGO's inclusion in Oppenheimer's 'Best Choices' list is perceived as positive news. The 12% gain over 24 hours and the MACD being above the signal line support upward pressure in the short term. However, with the RSI at 84.6 in overbought territory, a short-term correction is possible. Overall, market participants may maintain an upward price trend in the short term following this positive news. Nevertheless, a slight pullback within 1-3 days could be expected due to the overbought indicator.
RSI 14
84.6
MACD
10.29
24h Δ
12.00%
Canlı Grafikler
🔗 İlgili haberler
⭐ 78 · 5 sa önce
Broadcom ve Apple çip anlaşmasını 2031'e uzattı
⭐ 85 · 7 sa önce
SK Hynix US Listesi, Broadcom-Apple Anlaşması ve Solstice-Element Solutions Birleşme Gelişmeleri
⭐ 76 · 8 sa önce
Broadcom Hisseleri Apple ile Yeni Tedarik Anlaşması Sonrası Yükseldi
⭐ 76 · 9 sa önce
Broadcom, Apple İş Birliğini Genişletmesiyle %6 Yükseldi; AMD %10, Intel %5 Arttı
⭐ 65 · 10 sa önce
BlackRock ve Vanguard ETF'leri Yapay Zeka Rallisi Karşısında Ayrışıyor
⭐ 76 · 11 sa önce
Broadcom ve Apple Çip Tedarik Anlaşmasını 2031'e Uzattı
🧬 Buna benzer
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.